Skip to main content

Table 2 Relationship between clinical characteristics of ovarian cancer patients and the expression of LPAR1-3

From: LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study

 

Total (N)

LPAR1-Positive (%)

P value

LPAR2- Positive (%)

P value

LPAR3-Positive (%)

P value

 

52

36 (69.23)

 

22 (42.31)

 

9 (17.31)

 

Histological subtypes

0

 

0.664

 

0.587

 

0.542

 Serous

26

20 (76.925)

 

11 (42.31)

 

4 (15.38)

 

 Mucinous

8

5 (62.5 %)

 

3 (37.50)

 

2 (25.00)

 

 Endometroid

12

7 (58.33 %)

 

4 (33.33)

 

3 (25.00)

 

 Clear cell/Undifferentiated

6

4 (66.67 %)

 

4 (66.67)

 

0 (0)

 

Differentiation

  

0.415

 

0.002*

 

0.034*

 High

13

10 (76.92)

 

2 (15.38)

 

2 (15.38)

 

 Moderate

20

12 (60.00)

 

6 (30.00)

 

2 (10.00)

 

 Poor

19

14 (73.68)

 

14 (73.68)

 

5 (26.32)

 

Clinical stage

  

0.003*

 

0.712

 

0.678

 FIGO I

6

1 (16.67)

 

3 (50.00)

 

2 (33.33)

 

 FIGO II

8

4 (50.00)

 

3 (37.5)

 

2 (25.00)

 

 FIGO III

28

21 (75.00)

 

12 (42.86)

 

4 (14.29)

 

 FIGO IV

10

10 (100.00)

 

4 (40.00)

 

1 (10.00)

 
  1. * P <0.05 indicates statistically significant difference